Jing You

977 total citations
51 papers, 776 citations indexed

About

Jing You is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Jing You has authored 51 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Jing You's work include Protein Interaction Studies and Fluorescence Analysis (8 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Bone Tissue Engineering Materials (6 papers). Jing You is often cited by papers focused on Protein Interaction Studies and Fluorescence Analysis (8 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Bone Tissue Engineering Materials (6 papers). Jing You collaborates with scholars based in China, Ethiopia and United States. Jing You's co-authors include Hua‐jin Zeng, Lingbo Qu, Ran Yang, Yongming Hu, Haoshuang Gu, Zhenglong Hu, Tingting Qi, Ying Yuan, Chao‐Hung Ho and Chih‐Cheng Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Physics Letters and Journal of Applied Physics.

In The Last Decade

Jing You

45 papers receiving 763 citations

Peers

Countries citing papers authored by Jing You

Since Specialization

Citations

This map shows the geographic impact of Jing You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing You more than expected).

Fields of papers citing papers by Jing You

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing You. The network helps show where Jing You may publish in the future.

Co-authorship network of co-authors of Jing You

This figure shows the co-authorship network connecting the top 25 collaborators of Jing You. A scholar is included among the top collaborators of Jing You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing You. Jing You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetically predicted ankylosing spondylitis increases the risk of heart failure: a Mendelian randomization study 2025 ·Frontiers in Cardiovascular Medicine ·(unknown), Laicheng Wang, Lin Mei, Jing You, Xuan Zheng, Ailing Wang, (unknown), Feng Peng, (unknown)	0
2	Evolution of Industrial Robots from the Perspective of the Metaverse: Integration of Virtual and Physical Realities and Human–Robot Collaboration 2024 ·Applied Sciences ·Jing You, (unknown), (unknown), (unknown), (unknown)	3
3	Pegylated recombinant human granulocyte colony-stimulating factor for primary prophylaxis of neutropenia in patients with cervical cancer receiving concurrent chemoradiotherapy: a prospective study 2024 ·BMC Cancer ·Jing You, (unknown), (unknown), Weihu Wang, Xiaofan Li	0
4	Acute hematologic toxicity prediction using dosimetric and radiomics features in patients with cervical cancer: does the treatment regimen matter? 2024 ·Frontiers in Oncology ·Haizhen Yue, (unknown), Jing You, (unknown), Yi Du, Ruoxi Wang, Hao Wu, Jinsheng Cheng, (unknown), Bin Jing	2
5	Prognostic Factors Analysis of Metastatic Recurrence in Cervical Carcinoma Patients Treated with Definitive Radiotherapy: A Retrospective Study Using Mixture Cure Model 2023 ·Cancers ·(unknown), Jing You, (unknown), Xiaofan Li, (unknown), (unknown), (unknown), (unknown), Yibao Zhang	1
6	401P Utidelone in combination with etoposide and bevacizumab in HER2-negative breast cancer with brain metastasis (UTOBIA-BM): A prospective, single-arm, phase II trial 2023 ·Annals of Oncology ·Yu Shi, (unknown), (unknown), Xin Wang, Shumin Li, Bailin Zhang, Zhiyong Yuan, Jing You, Ying Zheng	2
7	High-Dose Versus Standard-Dose Intensity-Modulated Radiotherapy With Concurrent Paclitaxel Plus Carboplatin for Patients With Thoracic Esophageal Squamous Cell Carcinoma: A Randomized, Multicenter, Open-Label, Phase 3 Superiority Trial 2022 ·International Journal of Radiation OncologyBiologyPhysics ·Jing You, (unknown), Jiancheng Li, Jie Li, (unknown), (unknown), Xiaomin Li, Lin Jia, (unknown), H. J. Yang, Yiqun Wu, Wenbin Shen, Haishan Wu, (unknown), Xiaomin Wang, (unknown), Jun He, Pingping Lin, Guangying Zhu, Anhui Shi	18
8	An Adversarial Deep-Learning-Based Model for Cervical Cancer CTV Segmentation With Multicenter Blinded Randomized Controlled Validation 2021 ·Frontiers in Oncology ·Zhikai Liu, Wanqi Chen, Hui Guan, (unknown), Jing Shen, (unknown), An Liu, Richard Li, Jianhao Geng, Jing You, Weihu Wang, Zhouyu Li, Yongfeng Zhang, Yuanyuan Chen, (unknown), (unknown), Yu Chen, Shaobin Wang, (unknown), Jie Qiu	18
9	High Expression of Cancer-IgG Is Associated With Poor Prognosis and Radioresistance via PI3K/AKT/DNA-PKcs Pathway Regulation in Lung Adenocarcinoma 2021 ·Frontiers in Oncology ·(unknown), Guohui Wang, Jing You, (unknown), Xiaohong Xu, (unknown), Hao Wang, (unknown), Xiaoyan Qiu, Guangying Zhu	10
10	Adjuvant chemotherapy after radiotherapy or concurrent chemoradiotherapy for pelvic lymph node-positive patients with locally advanced cervical cancer: a propensity score matching analysis 2020 ·International Journal of Gynecological Cancer ·(unknown), Jing You, Xiaofan Li, Weihu Wang	14
11	Selection About Molten Salts Used For The Electrochemical Reduction of Porous TiO ₂ pellets 2020 ·Journal of The Electrochemical Society ·(unknown), (unknown), Yuezhong Di, Jianping Peng, Jing You, Feng Naixiang, Yi Zhang	4
12	Long-term follow-up of volumetric modulated arc therapy in definitive radiotherapy for cervical cancer: A single-center retrospective experience 2020 ·SHILAP Revista de lepidopterología ·(unknown), Jing You, Weihu Wang, Xiaofan Li	5
13	Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy 2018 ·Clinical Lung Cancer ·(unknown), Anhui Shi, Weihu Wang, Huiming Yu, Rong Yu, Dongming Li, Bo Xu, Huimin Ma, Jing You, Dan Zhao, (unknown), Jianhao Geng, Guangying Zhu	10
14	Dietary vitamin C intake and the risk of hip fracture: a dose-response meta-analysis 2017 ·Osteoporosis International ·Yadong Sun, (unknown), Yacong Bo, Jing You, Yuanyuan Zhu, Dandan Duan, (unknown), Quanjun Lü	25
15	Impact of FOXP3 Polymorphisms on the Blood Level of Tacrolimus in Renal Transplant Recipients 2016 ·Transplantation Proceedings ·Jie Ge, Jian Wang, (unknown), (unknown), Jing You, (unknown)	5
16	Inhibitory effects of daidzein and genistein on trypsin: Insights from spectroscopic and molecular docking studies 2016 ·International Journal of Biological Macromolecules ·Hua‐jin Zeng, Yaping Wang, Ran Yang, Jing You, Lingbo Qu	19
17	Molecular Interactions of Flavonoids to Hyaluronidase: Insights from Spectroscopic and Molecular Modeling Studies 2015 ·Journal of Fluorescence ·Hua‐jin Zeng, Jiao Ma, Ran Yang, Jing You, Lingbo Qu	28
18	Spectroscopic and molecular modeling investigation on the interactions between hyaluronidase and baicalein and chrysin 2015 ·Process Biochemistry ·Hua‐jin Zeng, (unknown), Jing You, Ran Yang, Lingbo Qu	13
19	Investigation on the binding interaction between silybin and pepsin by spectral and molecular docking 2014 ·International Journal of Biological Macromolecules ·Hua‐jin Zeng, Jing You, (unknown), Tingting Qi, Ran Yang, Lingbo Qu	50
20	Radiation therapy versus chemotherapy as initial treatmentfor localized nasal natural killer (NK)/T-cell lymphoma:a single institute survey in Taiwan 2004 ·Annals of Oncology ·Jing You, (unknown), (unknown), Chih‐Cheng Chen, Chao‐Hung Ho, Wing‐Keung Chau, Hui‐Chun Hsu, (unknown), (unknown), Liu H, (unknown), (unknown)	156

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact